Home/ Supplements/ Dim/ DIM - Avail

DIM - Avail

product on market Softgel Capsule Designs for Health Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Diindolylmethane is researched for its role in modulating estrogen metabolism and supporting hormonal balance. Current evidence for these effects is considered limited due to a lack of large-scale clinical trials. The ingredient profile maintains a high safety rating with no significant concerns noted.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for DIM - Avail
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
Non-Nutrient/Non-Botanical
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 200.0mg (3 products) 11 studies (A:1, B:3)

Other Ingredients

Medium chain triglycerides Mixed Tocopherols yellow Beeswax canola lecithin oil Gelatin Glycerine purified Water Annatto
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Recommended Use: As a dietary supplement, take one softgel per day with a meal, or as directed by your health care practitioner.

Warnings & Precautions

KEEP OUT OF REACH OF CHILDREN.

Formulation Notes

Does not contain gluten.

Additional Information

Notice: Color, size or shape may appear different between lots.

DIM060-1

For Professional Use Only

Guaranteed GMP COMPLIANT Products

MADE WITH NON-GMO INGREDIENTS

STORE IN A COOL, DRY PLACE.

Metadata

Product Details

UPC / SKU8 79452 00123 7
DSLD Entry Date2013-07-25
Product TypeNon-Nutrient/Non-Botanical
FormSoftgel Capsule
BrandDesigns for Health
DSLD ID22639
Data Updated2026-04-11
Research

Research Evidence

5
Research Sources
44
Avg Quality
5
Rct
C A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen
Rct Breast cancer research and treatment 2017 PubMed DOI
C Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomy
Rct European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2016 PubMed DOI
C Effectiveness of 3,3'-Diindolylmethane Supplements on Favoring the Benign Estrogen Metabolism Pathway and Decreasing Body Fat in Premenopausal Women
Rct Nutrition and cancer 2023 PubMed DOI
C The effects of light exposure on the cortisol stress response in human males.
Rct Stress (Amsterdam, Netherlands) PubMed DOI
D Pilot study: effect of 3,3'-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer
Rct Nutrition and cancer 2004 PubMed
View all evidence for Dim →
Dim research Best Dim All Dim products More from Designs for Health View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.